Loading...
Loading...
AKYA| Name | Value |
|---|---|
| Revenues | 21.4M |
| Cost of Revenue | 9.1M |
| Gross Profit | 12.3M |
| Operating Expense | 29.5M |
| Operating I/L | -17.2M |
| Other Income/Expense | -1.6M |
| Interest Income | 0.8M |
| Pretax | -18.8M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -18.8M |
Akoya Biosciences, Inc. provides spatial biology solutions for research and clinical applications. The company offers PhenoCycler and PhenoImager platforms, along with reagents and biopharma services, to automate image acquisition, visualize, analyze, and quantify cells in tissue sections. Additionally, it provides Proxima, inForm Tissue, Phenoptr, and phenoptrReports software for spatial data storage, analysis, and visualization. The company generates revenue through the sale of its instruments, reagents, and software, as well as through biopharma services.
